Arnold E. Markarov

Arnold E. Markarov

Auto-generated profile, based on publicly available information

Arnold E. Markarov

Inozemtsev City Clinical Hospital of the Department of Health of Moscow

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2022 in Medical alphabet
Verified
Journal Article
Closed access
PDF file
AMA. E. Markarov
A. E. Markarov
DED. A. Eremin
D. A. Eremin
AOA. I. Orazvaliev
A. I. Orazvaliev
AMA. V. Martirosov
A. V. Martirosov
NKN. M. Krasnov
N. M. Krasnov
ARA. A. Reut
A. A. Reut
Research objective. To stratify the main purulent-inflammatory diseases of maxilla-facial region (PID MFR) by frequencies and limits. To assess mortality in PID MFR. To determine the number of patients with PID MFR and concomitant diabetes mellitus.Resources and Methods. Medical documentation on 9550 patients with PID MFR hospitalized at F.I. Inozemtsev Municipal Clinical Hospital have been analyzed.Research results. The prevalence of purulent-inflammatory diseases remains at a fairly high level. PID MFR occur more often in people of young, able-bodied, age, 18–44 years. The introduction of quarantine measures due to the new coronavirus infection COVID-19 led to an increase in severe forms of PID MFR. There is a decrease in lethality from PID MFR.

1 January 2022 in Russian Rhinology
Verified
Journal Article
Closed access
AMA.A. Makarov
A.A. Makarov
AOA.I. Orazvaliev
A.I. Orazvaliev
RUR.V. Ushakov
R.V. Ushakov
EZE.V. Zhabko
E.V. Zhabko
В статье представлен анализ литературы, посвященной развитию мукормикоза у пациентов с новой коронавирусной инфекцией (COVID-19). Описан случай рино-орбито-церебрального мукормикоза, возникшего на фоне COVID-19 с острым началом заболевания. Приведены результаты лечения пациента с мукормикозом на разных этапах, данные фотопротокола и специальных методов исследования (компьютерная томография). Обоснована важность раннего применения междисциплинарного подхода к диагностике и лечению мукормикоза рино-орбитального комплекса.

19 April 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
OSO. A. Slyusareva
O. A. Slyusareva
AMA. E. Markarov
A. E. Markarov
SAS. V. Apresyan
S. V. Apresyan
JDJ. E. Dobrokhotova
J. E. Dobrokhotova
SKS. A. Khlynova
S. A. Khlynova
EME. A. Markova
E. A. Markova
Introduction. The efficacy of preoperative therapy with Gynestril in the treatment of symptomatic uterine fibroids and anaemia of various degrees of severity was studied in the prospective, comparative cohort study.Aim. To evaluate the efficacy of preoperative therapy with mifepristone in patients with uterine fibroids and chronic iron deficiency anaemia of various degrees of severity.Materials and methods. The study included 70 women who were scheduled to undergo the organ-preserving surgical treatment due to symptomatic uterine fibroids from January 1, 2017 to December 31, 2022. 50 patients received Gynestril at a dose of 50 mg/day (1 tablet) from day 1 of the menstrual cycle for 3 consecutive months. Due to contraindications to its use, 20 patients refused to administer the drug in the preoperative period and received symptomatic haemostatic therapy, and were included in the control groups. The patients of both groups received anti-anaemic therapy with iron(III)-hydroxide polymaltose tablets, 250– 300 mg/ day orally. 40 patients underwent the organ-preserving surgery depending on the size, number, type and localization of uterine fibroids according to the FIGO 2011 classification and patients’ motivation to preserve their reproductive function.Results. The analysis of changes in the laboratory test results revealed that hemoglobin levels in the groups after Gynestril therapy reached reference ranges in all women, averaging 123.4 ± 8.2 g/l as compared to the baseline value 84.3 ± 6.7 g/l, p < 0.05. It was also noted that ferritin levels increased significantly, averaging 12.2 ± 1.9 µg/l compared to the pre-treatment level 8.8 ± 0.8 µg/l, serum iron levels reached 12.8 ± 1.0 compared to the pre-treatment level 8.0 ± 0.8, and TIBC level reduced to 72.1 ± 3.5 compared to the pre-treatment level 96.7 ± 4.8 (p < 0.05).Conclusions. A comprehensive multidisciplinary approach to the treatment of uterine fibroids, including preoperative therapy with Gynestril, myomectomy using occlusive and X-ray endovascular techniques preserved the reproductive function in 50 patients with symptomatic uterine fibroids and anaemia of various degrees of severity.

11 December 2024 in Journal of Experimental and Clinical Surgery
Verified
Journal Article
Open access
PDF file
AAAndrey A. Alekseyev
Andrey A. Alekseyev
ABAlexander E. Bobrovnikov
Alexander E. Bobrovnikov
NMNatalia B. Malyutina
Natalia B. Malyutina
VBVitaly V. Bogdanov
Vitaly V. Bogdanov
NCNikolai M. Chilikin
Nikolai M. Chilikin
МБМалютина Наталья Борисовна
Малютина Наталья Борисовна
Rationale. Currently, there has been developed a technique for managing enzymatic necrolysis of II-III degree burn wounds using the two-component drug NexoBrid; this treatment option is possible to apply only in the early terms, up to 72 hours, after injury. There are no indications for the use of the technology in later terms after the injury. The aim of research was to study the potential and effectiveness of enzymatic necrolysis when using the drug NexoBrid in patients with burns of II-III degree at various stages after injury (before and after 72 hours). Methods. The study included 23 patients. In 15 cases, enzymatic necrolysis with Nexobrid was carried out in first 72 hours after injury; in 8 cases, in 5-9 days after injury. Results. In both groups, comparable results were obtained regarding the effectiveness of enzymatic necrolysis. The use of enzymatic necrolysis at the late stages (7 days) after injury was effective in the presence of moist necrotic tissue in the wounds, which allowed simultaneously, in the shortest possible time, cleaning burn wounds with uncomplete dermal necrosis (borderline burns of II degree and “mosaic” burns II-III degree) from necrosis, transforming wound process to second stage, creating conditions for regeneration of borderline and “mosaic” burns from the remaining skin derivatives with underlying use of dressings, thus creating a moist wound environment, and in the case of deep burns, reducing the time of their preparation and the area of autodermoplasty. Conclusion. The use of enzymatic necrolysis with the drug NexoBrid in patients with burns of II-III degree is effective up to 7 days after injury in the presence of a moist scab in the wounds.

11 May 2024 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
JDJu. E. Dobrokhotova
Ju. E. Dobrokhotova
AMA. E. Markarov
A. E. Markarov
MPM. A. Ponimanskaya
M. A. Ponimanskaya
SAS. V. Apresyan
S. V. Apresyan
SKS. A. Khlynova
S. A. Khlynova
OSO. A. Slyusareva
O. A. Slyusareva
Introduction. Uterine fibroids are ranked second and endometriosis is ranked third in the gynaecological pathology pattern. Uterine fibroids and endometriosis are among the most common diseases of the female genitalia and occur in every 4–5 gynaecological patients.Aim. To improve a multidisciplinary approach to the choice of surgical organ-preserving treatment strategies in hyperplastic diseases of the uterus using occlusion techniques.Materials and methods. A cohort prospective comparative study examined a multidisciplinary approach to the choice of surgical organ-preserving treatment strategies in uterine hyperplastic hysteropathies using occlusion techniques.Results. The study showed that uterine artery embolization is indicated if FIGO 2–5 fibroids’ size is > 4 cm in patients who are not planning pregnancy. The laparoscopic myomectomy with temporary uterine artery occlusion is provided if FIGO 2–6 fibroids’ size is from 6.0 to 8.0 cm, the laparoscopic myomectomy with temporary balloon occlusion of the internal iliac arteries is the procedure of choice if fibroids’ size is from 8.0 to 12.0 cm and they are located in the cervical-isthmus region and in areas of vascular bundles, and vaginal myomectomy with temporary balloon occlusion of the common iliac arteries is performed if FIGO 8 fibroids’ size is > 4 cm and they are located in the cervix. If adenomyosis nodes’ size is from 4.0 to 6.0 cm, they are removed using laparoscopic access with temporary occlusion of the uterine arteries; if adenomyosis nodes’ size is ≥ 6.0 cm, they are removed using laparoscopic access with temporary balloon occlusion of the internal iliac arteries.Conclusion. The multidisciplinary approach in the treatment of hyperplastic diseases of the uterus is regarded as optimal.

7 October 2022 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
AMA. E. Markarov
A. E. Markarov
JDJu. E. Dobrokhotova
Ju. E. Dobrokhotova
SKS. A. Khlynova
S. A. Khlynova
VDV. I. Dimitrova
V. I. Dimitrova
SPS. A. Papoyan
S. A. Papoyan
SAS. S. Apresyan
S. S. Apresyan
   Introduction. The necessity to improve methods of adenomyosis treatment is determined not only by its high prevalence, which reaches 40 % among women of reproductive age, but also by its association with infertility of unclear genesis. The disease significantly reduces the quality of life.   Objective. To optimize reproductive outcomes after surgical treatment of nodular adenomyosis and to prevent the disease recurrence.   Materials and Methods. A cohort prospective comparative study examined the efficacy of therapy with dienogestam after laparoscopic removal of adenomyosis nodules with temporary uterine artery occlusion and temporary balloon occlusion of the internal iliac arteries. The study included 25 women who underwent organ-preserving treatment for nodular adenomyosis from January 1, 2020 to January 1, 2022. Inclusion criteria: age 22–45 years, mean 32 ± 4.5; organ preserving treatment for nodular adenomyosis, no contraindications to hormone therapy, informed voluntary consent of the patient to participate in the study.   Results. The use of Dientogest at a dose of 2 mg/day in a continuous regimen for 6 months after surgical treatment for nodular adenomyosis was shown to transform the intensity of pain syndrome to insignificant, the absence of recurrent disease for 24 months of follow-up.   Conclusions. The comprehensive treatment of nodular adenomyosis, which included laparoscopic removal of the nodule and the drug therapy with dienogestam, permitted the achievement of reproductive function in 40% of the patients. The choice of the treatment method for nodular adenomyosis depends primarily on the reproductive plans of the patient, the size and location of the adenomyosis nodules, and its long-term results depend on the comprehensive antiretroviral therapy.